Derrame pleural e hipertensión pulmonar en un paciente con enfermedad de Parkinson en tratamiento con cabergolina

Haro-Estarriol, Manuel; Sabater-Talaverano, Gladis; Rodríguez-Jerez, Francisco; Obrador-Lagares, Anton; Genís-Batlle, David; Sendra-Salillas, Salvi.
Arch. bronconeumol. (Ed. impr.) ; 45(2): 100-102, feb. 2009. ilus
Artículo en Español | IBECS (España) | ID: ibc-59877

Documentos relacionados

  1. [Pleural effusion and pulmonary hypertension in a patient with Parkinson disease treated with cabergoline].
  2. [Early pleuropulmonary toxicity associated with cabergoline, an antiparkinsonian drug].
  3. [Two cases of patients with Parkinson's disease developing valvular heart disease while taking cabergoline].
  4. Long-term effects of cabergoline and levodopa in Japanese patients with early Parkinson's disease: a 5-year prospective study.
  5. Cabergoline : a review of its use in the treatment of Parkinson's disease.
  6. Effect of Cabergoline Treatment on Disease Control in Acromegaly Patients.
  7. Dopamine agonists and the risk of cardiac-valve regurgitation.
  8. AACE/ACE Disease State Clinical Review: Dopamine Agonists for Hyperprolactinemia and the Risk of Cardiac Valve Disease.
  9. [Mitral valve replacement for cabergoline-related severe mitral regurgitation].
  10. Parkinson's drugs linked to heart valve trouble.